After hours: February 28 at 5:16:11 PM EST Loading Chart for ELAN ...

On Tuesday, Elanco Animal Health Incorporated (NYSE:ELAN) reported fourth-quarter revenue of $1.02 billion, a decrease of 1% on a reported basis or a 4% organic constant currency growth ...

Elanco Animal Health (NYSE:ELAN) traded lower in the premarket on Tuesday after the veterinary product maker, with its Q4 2024 results, set its full-year outlook below consensus, citing an ...

Elanco (ELAN) has entered into an agreement with South Dakota-based Medgene to leverage the company’s innovative vaccine platform technology. The agreement includes commercialization of a highly ...

Elanco’s Q4 revenue hit $1.02B, beating estimates, while adjusted EPS of $0.14 missed the $0.15 consensus. 2025 revenue guidance of $4.45B-$4.51B trails the $4.53B consensus, with FX headwinds ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Elanco said a cattle vaccine will be critical to slow transmission between birds and cattle, a potential catalyst as a bird flu outbreak has roiled farms and sent egg prices soaring. "As egg ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Elanco Animal Health (ELAN – Research Report), with a price target of $20.00. The company’s shares closed ...